Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical studyOsamu Yoshida, Yoichi Hiasa, Yusuke Imai et al.|Hepatology Research|2022Cited by 24